Elevated day 3 serum follicle stimulating hormone and/or estradiol may predict fetal aneuploidy

Keyphrases

• Abortus 25%
• Autosomal Trisomy 25%
• Balanced Translocation 25%
• Controlled Ovarian Stimulation 25%
• Curettage 50%
• Design Case 25%
• Embryo Transfer 25%
• Estradiol 100%
• Fetal Aneuploidy 100%
• Fetal Chromosomal Abnormalities 25%
• Fetal Karyotype 100%
• Follicle-stimulating Hormone 100%
• Gametes 25%
• Genetic Evaluation 25%
• Hospitalized Patients 25%
• Immulite 50%
• In Vitro Embryo Production 25%
• In Vitro Fertilization 25%
• Intrauterine Insemination 25%
• Monosomy 25%
• Mosaicism 25%
• Natural Conception 25%
• Products of Conception 25%
• Reproductive Technologies 25%
• Technology Programs 25%
• Triploidy 25%
• University Hospital 25%
• With Woman 25%
• Zygote Intrafallopian Transfer 25%

Medicine and Dentistry

• Aneuploidy 100%
• Case-Control Study 25%
• Chromosome Aberration 25%
• Conception 50%
• Controlled Ovarian Hyperstimulation 25%
• Diethylstilbestrol 100%
• Dilation and Curettage 50%
• Embryo Transfer 25%
• Follitropin 100%
• Gamete Intrafallopian Transfer 25%
• Genetic Evaluation 25%
• In Vitro Fertilisation 25%
• Intrauterine Insemination 25%
• Karyotype 100%
• Monosomy 25%
• Mosaicism 25%
• Reproductive Technology 25%
• Triploidy 25%
• Trisomy 25%
• Zygote Intrafallopian Transfer 25%

Biochemistry, Genetics and Molecular Biology

• Aneuploidy 100%
• Autosomal Trisomies 25%
• Case-Control Study 25%
• Chromosomal Abnormalities 25%
• Conception 50%
• Embryo Transfer 25%
• Estradiol 100%
• Follitropin Blood Level 100%
• Gamete 25%
• Genetic Evaluation 25%
• In Vitro Fertilisation 25%
• Insemination 25%
• Karyotype 100%
• Monosomy 25%
• Mosaicism 25%
• Triploidy 25%